|
Cryolife, Inc. - Company Profile Snapshot
| Company Profile: |
Cryolife, Inc. |
| Ticker: |
CRY |
| Exchanges: |
NYSE |
| 2008 Sales: |
105,060,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
UNITED STATES |
| Employees: |
435 |
Business Description
Cryolife, Inc.. The Group's principal activities are to develop and commercialize biomaterials, implantable medical devices. it also preserve and distribute human tissues for cardiovascular and vascular transplant applications. The Group operates in two segments: Implantable Medical Devices and Preservation Services. The Implantable medical devices segment includes the sales of BioGlue and bioprosthetic devices, including stentless porcine heart valves and SynerGraft processed bovine vascular grafts. The Preservation Services segment includes the preservation of cardiac, vascular, and orthopaedic allograft tissues. The Group's products are marketed in the United States, Europe, the Middle East, Canada, Australia and Asia.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
